Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways
As freshwater sources continue to be influenced by wastewater effluents, there is a dire need to develop advanced water treatment processes capable of treating the wastewater-derived contaminants, especially for pharmaceutically active compounds (PhACs). Ultraviolet light (UV) combined with calcium...
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/153429 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-153429 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1534292021-12-04T20:11:28Z Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways Zheng, Ming Daniels, Kevin D. Park, Minkyu Nienhauser, Alec Brockway Clevenger, Erica C. Li, Yongmei Snyder, Shane Allen Nanyang Environment and Water Research Institute Engineering::Environmental engineering::Water treatment Pharmaceutically Active Compounds UV/CaO₂ As freshwater sources continue to be influenced by wastewater effluents, there is a dire need to develop advanced water treatment processes capable of treating the wastewater-derived contaminants, especially for pharmaceutically active compounds (PhACs). Ultraviolet light (UV) combined with calcium peroxide (CaO2) as an advanced oxidation process (AOP) to attenuate five widespread PhACs (carbamazepine (CBZ), primidone (PMD), phenobarbital (PBB), thiamphenicol (TAP) and florfenicol (FF)) was investigated in this paper. The degradation of these compounds followed pseudo-first-order kinetics (R2 > 0.96). The optimum CaO2 dosage was 0.1 g L-1 and lower initial contaminants concentration was beneficial to their degradation. The UV/CaO2 treatment of test PhACs was attributed to the combination of UV/H2O2 and UV-base-photolysis (UV/Ca(OH)2), and the degradation mechanism was recognized as both UV direct photolysis and indirect photolysis caused by reactive radicals (•OH, triplet states of dissolved organic matter (3DOM*), and 1O2). Furthermore, the tentative transformation pathways of the five PhACs were proposed based on the detected intermediates and the degradation mechanisms. The final products of inorganic carbon and nitrogen indicate UV/CaO2 treatment can significantly mineralize test PhACs. Also, the CaO2 addition significantly reduced the energy consumption of UV irradiation according to electrical energy per order. The effective removal of CBZ and PMD in a secondary wastewater effluent by UV/CaO2 treatment demonstrates the potential use of this AOP technology in advanced treatment of wastewater-derived PhACs. Accepted version 2021-12-01T07:45:53Z 2021-12-01T07:45:53Z 2019 Journal Article Zheng, M., Daniels, K. D., Park, M., Nienhauser, A. B., Clevenger, E. C., Li, Y. & Snyder, S. A. (2019). Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways. Water Research, 164, 114922-. https://dx.doi.org/10.1016/j.watres.2019.114922 0043-1354 https://hdl.handle.net/10356/153429 10.1016/j.watres.2019.114922 31382152 2-s2.0-85071712621 164 114922 en Water Research © 2019 Elsevier Ltd. All rights reserved. This paper was published in Water Research and is made available with permission of Elsevier Ltd.. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Engineering::Environmental engineering::Water treatment Pharmaceutically Active Compounds UV/CaO₂ |
spellingShingle |
Engineering::Environmental engineering::Water treatment Pharmaceutically Active Compounds UV/CaO₂ Zheng, Ming Daniels, Kevin D. Park, Minkyu Nienhauser, Alec Brockway Clevenger, Erica C. Li, Yongmei Snyder, Shane Allen Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
description |
As freshwater sources continue to be influenced by wastewater effluents, there is a dire need to develop advanced water treatment processes capable of treating the wastewater-derived contaminants, especially for pharmaceutically active compounds (PhACs). Ultraviolet light (UV) combined with calcium peroxide (CaO2) as an advanced oxidation process (AOP) to attenuate five widespread PhACs (carbamazepine (CBZ), primidone (PMD), phenobarbital (PBB), thiamphenicol (TAP) and florfenicol (FF)) was investigated in this paper. The degradation of these compounds followed pseudo-first-order kinetics (R2 > 0.96). The optimum CaO2 dosage was 0.1 g L-1 and lower initial contaminants concentration was beneficial to their degradation. The UV/CaO2 treatment of test PhACs was attributed to the combination of UV/H2O2 and UV-base-photolysis (UV/Ca(OH)2), and the degradation mechanism was recognized as both UV direct photolysis and indirect photolysis caused by reactive radicals (•OH, triplet states of dissolved organic matter (3DOM*), and 1O2). Furthermore, the tentative transformation pathways of the five PhACs were proposed based on the detected intermediates and the degradation mechanisms. The final products of inorganic carbon and nitrogen indicate UV/CaO2 treatment can significantly mineralize test PhACs. Also, the CaO2 addition significantly reduced the energy consumption of UV irradiation according to electrical energy per order. The effective removal of CBZ and PMD in a secondary wastewater effluent by UV/CaO2 treatment demonstrates the potential use of this AOP technology in advanced treatment of wastewater-derived PhACs. |
author2 |
Nanyang Environment and Water Research Institute |
author_facet |
Nanyang Environment and Water Research Institute Zheng, Ming Daniels, Kevin D. Park, Minkyu Nienhauser, Alec Brockway Clevenger, Erica C. Li, Yongmei Snyder, Shane Allen |
format |
Article |
author |
Zheng, Ming Daniels, Kevin D. Park, Minkyu Nienhauser, Alec Brockway Clevenger, Erica C. Li, Yongmei Snyder, Shane Allen |
author_sort |
Zheng, Ming |
title |
Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
title_short |
Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
title_full |
Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
title_fullStr |
Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
title_full_unstemmed |
Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO₂ process : influencing factors, degradation mechanism and pathways |
title_sort |
attenuation of pharmaceutically active compounds in aqueous solution by uv/cao₂ process : influencing factors, degradation mechanism and pathways |
publishDate |
2021 |
url |
https://hdl.handle.net/10356/153429 |
_version_ |
1718368092295266304 |